丙酸氟替卡松吸入气雾剂联合沙美特罗替卡松气雾剂治疗儿童哮喘效果分析

摘要

Objective To explore the clinical effect of Seretide assisted Flixotide in the treatment of childhood asthma.Methods 76 children with asthma who were diagnosed and treated in our hospital and randomly divided into the observation group and the control group. The observation group were given flixotide and Seretide for inhalation therapy. The control group were treated with flixotide inhalation therapy only. Compared the clinical effect and lung function of two groups after three months of treatment.Results In the observation group,the total effective rate was 94.7%,and the total effective rate of the control group was 84.2%. The improvement of lung function of the observation group was significantly better than the control group,al the differences were statisticaly significant(P<0.05).Conclusion Seretide assisted Flixotide in the treatment of childhood asthma has significant effect.%目的 探究丙酸氟替卡松吸入气雾剂(辅舒酮)联合沙美特罗替卡松气雾剂(舒利迭)治疗儿童哮喘过程中的临床疗效.方法 随机选取2013年1月~2015年4月在我院确诊并接受治疗的76例患有哮喘的儿童患者,并随机平均分为观察组、对照组两组,每组38例.观察组患者给予辅舒酮联合舒利迭吸入治疗,对照组患者给予辅舒酮吸入治疗.比较两组患者治疗3个月后的临床效果以及患者肺功能.结果 观察组38例患者中,总有效率94.7%;对照组患者中总有效率84.2%.观察组患者的治疗效果优于对照组,而且观察组患者的肺功能改善程度优于对照组,差异均具有统计学意义(P<0.05).结论 辅舒酮联合舒利迭治疗儿童哮喘疗效良好.